Clinical Trials Insight: 700024170

Trial Profile

Clinical Trials Insight: 700024170

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2009

At a glance

  • Drugs AVN 944 (Primary)
  • Indications Autoimmune disorders; Haematological malignancies; Pancreatic cancer
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Avalon Pharmaceuticals
  • Most Recent Events

    • 01 Jan 2009 Status changed from active, no longer recruiting to completed.
    • 01 Jan 2009 Results reported in the Journal of Clinical Pharmacololgy.
    • 27 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top